Duvelisib, sold under the brand name Copiktra, is a medication used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and...
19 KB (1,338 words) - 07:08, 18 July 2024
Pharmaceuticals to duvelisib (IPI-145), a novel inhibitor of PI3K delta and gamma. In April 2018, Verastem filed a New Drug Application (NDA) for duvelisib for the...
9 KB (726 words) - 12:52, 13 July 2024
Duvelisib (codenamed INK1197, IPI-145; PIK3CD and PIK3CG inhibitor): The results of the completed pivotal phase III trial DUO comparing duvelisib monotherapy...
45 KB (5,359 words) - 22:07, 19 July 2024
in patients who have received at least two prior systemic therapies. Duvelisib is approved for relapsed/refractory chronic lymphocytic leukemia/small...
36 KB (4,322 words) - 16:42, 6 October 2023
Pharmaceuticals entered into a global collaboration to develop and commercialize duvelisib, Infinity's PI3K inhibitor for the treatment of patients with cancer....
40 KB (3,359 words) - 06:40, 2 August 2024
Panobinostat Romidepsin Vorinostat) PIKI (Pi3K) (Alpelisib Copanlisib Duvelisib Idelalisib Umbralisib‡) Receptor antagonists ERA (Atrasentan) Retinoid...
31 KB (2,940 words) - 06:07, 28 February 2024
Panobinostat Romidepsin Vorinostat) PIKI (Pi3K) (Alpelisib Copanlisib Duvelisib Idelalisib Umbralisib‡) Receptor antagonists ERA (Atrasentan) Retinoid...
36 KB (3,273 words) - 09:54, 29 July 2024
Panobinostat Romidepsin Vorinostat) PIKI (Pi3K) (Alpelisib Copanlisib Duvelisib Idelalisib Umbralisib‡) Receptor antagonists ERA (Atrasentan) Retinoid...
5 KB (324 words) - 12:07, 20 July 2024
the withdrawal of every other PI3K inhibitor for follicular lymphoma: duvelisib in December 2021, umbralisib in January 2022, and copanlisib in November...
16 KB (1,254 words) - 06:35, 1 July 2024
Panobinostat Romidepsin Vorinostat) PIKI (Pi3K) (Alpelisib Copanlisib Duvelisib Idelalisib Umbralisib‡) Receptor antagonists ERA (Atrasentan) Retinoid...
19 KB (1,681 words) - 07:11, 15 March 2024
Panobinostat Romidepsin Vorinostat) PIKI (Pi3K) (Alpelisib Copanlisib Duvelisib Idelalisib Umbralisib‡) Receptor antagonists ERA (Atrasentan) Retinoid...
20 KB (1,809 words) - 03:48, 24 July 2024
Panobinostat Romidepsin Vorinostat) PIKI (Pi3K) (Alpelisib Copanlisib Duvelisib Idelalisib Umbralisib‡) Receptor antagonists ERA (Atrasentan) Retinoid...
89 KB (10,338 words) - 14:21, 16 July 2024
Panobinostat Romidepsin Vorinostat) PIKI (Pi3K) (Alpelisib Copanlisib Duvelisib Idelalisib Umbralisib‡) Receptor antagonists ERA (Atrasentan) Retinoid...
27 KB (2,564 words) - 02:20, 16 July 2024
Panobinostat Romidepsin Vorinostat) PIKI (Pi3K) (Alpelisib Copanlisib Duvelisib Idelalisib Umbralisib‡) Receptor antagonists ERA (Atrasentan) Retinoid...
33 KB (2,959 words) - 02:09, 16 July 2024
Panobinostat Romidepsin Vorinostat) PIKI (Pi3K) (Alpelisib Copanlisib Duvelisib Idelalisib Umbralisib‡) Receptor antagonists ERA (Atrasentan) Retinoid...
25 KB (2,177 words) - 19:13, 22 July 2024
Panobinostat Romidepsin Vorinostat) PIKI (Pi3K) (Alpelisib Copanlisib Duvelisib Idelalisib Umbralisib‡) Receptor antagonists ERA (Atrasentan) Retinoid...
5 KB (210 words) - 06:16, 5 July 2024
Panobinostat Romidepsin Vorinostat) PIKI (Pi3K) (Alpelisib Copanlisib Duvelisib Idelalisib Umbralisib‡) Receptor antagonists ERA (Atrasentan) Retinoid...
31 KB (2,754 words) - 19:14, 24 July 2024
and acalabrutinib (Bruton's tyrosine kinase inhibitors), idelalisib and duvelisib (inhibitors of some forms of the enzyme phosphoinositide 3-kinase), as...
73 KB (7,597 words) - 17:09, 3 August 2024
Panobinostat Romidepsin Vorinostat) PIKI (Pi3K) (Alpelisib Copanlisib Duvelisib Idelalisib Umbralisib‡) Receptor antagonists ERA (Atrasentan) Retinoid...
61 KB (6,082 words) - 05:23, 17 June 2024
Panobinostat Romidepsin Vorinostat) PIKI (Pi3K) (Alpelisib Copanlisib Duvelisib Idelalisib Umbralisib‡) Receptor antagonists ERA (Atrasentan) Retinoid...
13 KB (1,449 words) - 02:14, 10 July 2024
Panobinostat Romidepsin Vorinostat) PIKI (Pi3K) (Alpelisib Copanlisib Duvelisib Idelalisib Umbralisib‡) Receptor antagonists ERA (Atrasentan) Retinoid...
44 KB (4,623 words) - 22:26, 10 May 2024
Panobinostat Romidepsin Vorinostat) PIKI (Pi3K) (Alpelisib Copanlisib Duvelisib Idelalisib Umbralisib‡) Receptor antagonists ERA (Atrasentan) Retinoid...
31 KB (2,821 words) - 10:12, 17 July 2024
KRAS inhibitors Adagrasib Sotorasib Pi3K inhibitors Alpelisib Copanlisib Duvelisib Idelalisib Parsaclisib Cabozantinib Capmatinib Entrectinib Erdafitinib...
12 KB (760 words) - 03:40, 23 July 2024
Panobinostat Romidepsin Vorinostat) PIKI (Pi3K) (Alpelisib Copanlisib Duvelisib Idelalisib Umbralisib‡) Receptor antagonists ERA (Atrasentan) Retinoid...
19 KB (1,553 words) - 19:42, 17 May 2024
Panobinostat Romidepsin Vorinostat) PIKI (Pi3K) (Alpelisib Copanlisib Duvelisib Idelalisib Umbralisib‡) Receptor antagonists ERA (Atrasentan) Retinoid...
20 KB (1,915 words) - 00:12, 31 March 2024
Panobinostat Romidepsin Vorinostat) PIKI (Pi3K) (Alpelisib Copanlisib Duvelisib Idelalisib Umbralisib‡) Receptor antagonists ERA (Atrasentan) Retinoid...
3 KB (98 words) - 05:18, 1 January 2024
Panobinostat Romidepsin Vorinostat) PIKI (Pi3K) (Alpelisib Copanlisib Duvelisib Idelalisib Umbralisib‡) Receptor antagonists ERA (Atrasentan) Retinoid...
5 KB (290 words) - 20:59, 6 January 2024
Panobinostat Romidepsin Vorinostat) PIKI (Pi3K) (Alpelisib Copanlisib Duvelisib Idelalisib Umbralisib‡) Receptor antagonists ERA (Atrasentan) Retinoid...
15 KB (1,438 words) - 02:57, 10 May 2024
Panobinostat Romidepsin Vorinostat) PIKI (Pi3K) (Alpelisib Copanlisib Duvelisib Idelalisib Umbralisib‡) Receptor antagonists ERA (Atrasentan) Retinoid...
4 KB (128 words) - 11:38, 22 April 2024
Panobinostat Romidepsin Vorinostat) PIKI (Pi3K) (Alpelisib Copanlisib Duvelisib Idelalisib Umbralisib‡) Receptor antagonists ERA (Atrasentan) Retinoid...
12 KB (1,052 words) - 10:08, 29 January 2024